APPs |
acute phase proteins |
ARFI |
Acoustic Radiation Force Impulse |
Ca15-3 |
cancer antigen 15-3 |
CDK |
cyclin -dependent kinases |
CEA |
carcinoembryonic antigen |
CEUS |
contrast-enhanced ultrasound |
CCL2 |
CC chemokine ligand 2 |
CGS |
cytological grading system |
CMT |
canine mammary tumor |
CMTs |
canine mammary tumors |
COX-2 |
cyclo-oxygenase-2 |
CRP |
C- reactive protein |
DEGs |
differentially expressed genes |
E-cadherin |
epithelial cadherin |
ER |
estrogen receptor |
ER+ |
estrogen receptor positive |
ER- |
estrogen receptor negative |
FNAC |
fine needle aspiration cytology |
HER-2 |
human epidermal receptor 2 |
HSPs |
heat shock proteins |
HBC |
human breast cancer |
HBCs |
human breast cancers |
iNOS |
isoform of nitric oxide |
iTIM |
intratumoral tumor-infiltrating macrophages |
Ki-67 |
antigen Ki-67 |
miRNA |
microRNAs |
MS |
mass spectrometry |
NOS |
invasive ductal carcinoma |
NMR |
nuclear magnetic resonance |
OHE |
ovariohysterectomy |
OTR |
oxytocin receptor |
PD-1 |
programmed cell death protein-1 |
PR |
progesterone receptor |
PR+ |
progesterone receptor positive |
PR- |
progesterone receptor negative |
SR |
strain ratio |
SSMC |
staging system of mammary carcinomas |
sTIMs |
stromal tumor-infiltrating macrophages |
VEGF |
vascular endothelial growth factor |
VEGFR2 |
vascular endothelial growth factor receptor 2 |
TIMs |
tumor-infiltrating macrophages |
TGF-β1 |
tumor growth factor-β1 |
TNBC |
triple-negative breast cancer |
TNF-α |
tumor necrosis factor-α |
TNM |
tumor size (T), nodal stage (N), distant metastasis (M) |
tTIMs |
total count tumor-infiltrating macrophages |
WES |
whole-exome sequencing |
WTS |
whole-transcriptome sequencing |